ATYR Atyr Pharma, Inc.
Fundamentals / CIK 0001339970 / USDAtyr Pharma, Inc. reported $190K in revenue and a net loss of $53.32M for the fiscal year ended December 31, 2025 (down 19.1% year over year), with a -29423.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATYR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$190K -19.1% YoY
-
Operating Income FY 2025-$55.91M -29423.7% margin
-
Net Income FY 2025-$53.32M -28065.3% net margin
-
Diluted EPS FY 2025-$21.71 Split-adjusted
-
Free Cash Flow FY 2025-$43.86M -23085.3% FCF margin
-
Cash & ST Investments Sep 30, 2026$48.75M Total debt: $10.92M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $190K | $235K | $353K | $10.39M | $0 | $10.46M | $422K | -- | -- | -- |
| Research & Development | $60.22M | $54.37M | $42.29M | $42.81M | $23.26M | $17.29M | $14.05M | $20.39M | $30.07M | $42.85M |
| Total Operating Expenses | $77.82M | $68.15M | $55.27M | $56.79M | $34.02M | $26.37M | $23.40M | $32.82M | $47.15M | $57.94M |
| Operating Income | -$77.63M | -$67.91M | -$54.92M | -$46.40M | -$34.02M | -$15.91M | -$22.98M | -$32.82M | -$47.15M | -$57.94M |
| EBITDA | -$76.96M | -$67.21M | -$54.33M | -$46.17M | -$33.54M | -$15.34M | -$22.34M | -$32.07M | -$46.43M | -$57.04M |
| Income Before Tax | -$74.12M | -$64.02M | -$50.40M | -$45.34M | -$33.77M | -$16.23M | -$23.76M | -$34.52M | -$48.21M | -$57.90M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- | -$49K |
| Net Income | -$74.12M | -$64.02M | -$50.39M | -$45.34M | -$33.77M | -$16.22M | -$16.22M | -$34.52M | -$48.21M | -$57.85M |
| Basic EPS | -$32.00 | -$34.40 | -$37.60 | -$64.00 | -$70.80 | -$70.80 | -$281.20 | -$644.40 | -$1,045.20 | -$97.60 |
| Diluted EPS | -$32.00 | -$34.40 | -$37.60 | -$64.00 | -$70.80 | -$70.80 | -$281.20 | -$644.40 | -$1,045.20 | -$97.60 |
| Basic Shares Outstanding | 2.3M | 1.9M | 1.3M | 710.5K | 477.0K | 229.0K | 83.9K | 53.5K | 46.1K | 592.0K |
| Diluted Shares Outstanding | 2.3M | 1.9M | 1.3M | 710.5K | 477.0K | 229.0K | 83.9K | 53.5K | 46.1K | 592.0K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | -- | -- | $0 | $190K | $0 | $0 | $0 |
| Research & Development | $10.45M | $6.75M | $7.32M | $10.89M | $22.13M | $15.38M | $11.81M | $12.23M |
| Total Operating Expenses | $18.79M | $10.88M | $11.44M | $14.80M | $26.93M | $20.31M | $15.77M | $15.82M |
| Operating Income | -$18.79M | -$10.88M | -$11.44M | -$14.80M | -$26.75M | -$20.31M | -$15.77M | -$15.82M |
| EBITDA | -$18.62M | -$10.71M | -$11.27M | -$14.63M | -$26.58M | -$20.15M | -$15.61M | -$15.64M |
| Net Income | -$18.26M | -$10.31M | -$10.79M | -$13.96M | -$25.74M | -$19.53M | -$14.88M | -$14.97M |
| Basic EPS | -$7.43 | -$4.40 | -$4.40 | -- | -$10.60 | -$8.80 | -$6.80 | -- |
| Diluted EPS | -$7.43 | -$4.40 | -$4.40 | -- | -$10.60 | -$8.80 | -$6.80 | -- |
| Basic Shares Outstanding | 2.5M | 2.5M | 2.5M | -- | 2.4M | 2.3M | 2.2M | -- |
| Diluted Shares Outstanding | 2.5M | 2.5M | 2.5M | -- | 2.4M | 2.3M | 2.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $10.74M | $11.05M | $22.54M | $9.98M | $2.34M | $16.95M | $9.21M | $22.96M | $21.09M | $38.39M |
| Short-Term Investments | $67.94M | $61.07M | $75.62M | $56.16M | $105.6M | $14.74M | $21.93M | $26.58M | $64.03M | $33.76M |
| Cash & Short-Term Investments | $78.69M | $72.12M | $98.17M | $66.15M | $107.9M | $31.69M | $31.14M | $49.55M | $85.12M | $72.15M |
| Total Current Assets | $80.24M | $81.95M | $103.0M | $80.87M | $113.6M | $35.53M | $31.93M | $50.80M | $86.98M | $74.77M |
| Property, Plant & Equipment, Net | $4.26M | $4.85M | $5.53M | $3.06M | $543K | $899K | $1.27M | $1.85M | $2.28M | $1.42M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $4.00M |
| Other Non-Current Assets | $148K | $66K | $131K | $193K | $158K | $213K | $172K | $90K | $90K | $333K |
| Total Non-Current Assets | $12.77M | $14.88M | $17.66M | $14.91M | $1.97M | $3.19M | $4.26M | $1.94M | $2.37M | $5.76M |
| Total Assets | $93.00M | $96.83M | $120.7M | $95.79M | $115.5M | $38.73M | $36.19M | $52.75M | $89.36M | $80.52M |
| Accounts Payable | $3.89M | $4.32M | $3.53M | $3.11M | $1.03M | $1.43M | $847K | $1.04M | $2.28M | $2.61M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $8.74M | $7.77M | $5.01M | $339K |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $208K | -- | -- | -- |
| Total Current Liabilities | $15.15M | $14.97M | $16.42M | $13.86M | $6.01M | $5.86M | $12.92M | $10.83M | $10.39M | $8.53M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $8.26M | $14.72M | $9.20M |
| Total Non-Current Liabilities | $10.57M | $12.03M | $13.77M | $10.64M | $398K | $1.38M | $2.24M | $8.26M | $14.72M | $9.20M |
| Total Liabilities | $25.71M | $27.00M | $30.18M | $24.50M | $6.41M | $7.24M | $15.16M | $19.10M | $25.11M | $17.72M |
| Total Debt (incl. Leases) | $12.03M | $13.28M | $15.39M | $14.29M | $1.38M | $2.24M | $11.73M | $16.03M | $19.73M | $9.54M |
| Common Stock | $98K | $84K | $63K | $29K | $28K | $11K | $4.0K | $2.0K | $30K | $24K |
| Retained Earnings | -$606.2M | -$532.0M | -$468.0M | -$417.6M | -$372.3M | -$338.5M | -$322.3M | -$298.7M | -$264.2M | -$216.0M |
| Accumulated Other Comp. Income | -$8.0K | -$40K | -$74K | -$433K | -$263K | -$43K | -$40K | -$60K | -$120K | -$76K |
| Total Stockholders' Equity | $67.48M | $70.02M | $90.66M | $71.46M | $109.3M | $31.65M | $21.19M | $33.65M | $64.25M | $62.80M |
| Total Equity | $67.29M | $69.83M | $90.47M | $71.28M | $109.1M | $31.48M | $21.03M | $33.65M | $64.25M | $62.80M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.14M | $16.16M | $10.01M | $10.74M | $6.15M | $17.22M | $10.36M | $11.05M |
| Short-Term Investments | $35.61M | $41.26M | $56.51M | $67.94M | $79.00M | $63.13M | $65.99M | $61.07M |
| Cash & Short-Term Investments | $48.75M | $57.42M | $66.51M | $78.69M | $85.15M | $80.35M | $76.35M | $72.12M |
| Total Current Assets | $50.16M | $58.36M | $67.58M | $80.24M | $93.01M | $87.49M | $83.27M | $81.95M |
| Property, Plant & Equipment, Net | $3.38M | $4.13M | $4.24M | $4.26M | $4.43M | $4.53M | $4.68M | $4.85M |
| Long-Term Investments | -- | -- | -- | -- | $5.10M | -- | -- | -- |
| Other Non-Current Assets | $238K | $190K | $148K | $148K | $149K | $66K | $66K | $66K |
| Total Non-Current Assets | $9.65M | $11.46M | $12.08M | $12.77M | $13.64M | $14.04M | $13.97M | $14.88M |
| Total Assets | $59.81M | $69.83M | $79.65M | $93.00M | $106.7M | $101.5M | $97.25M | $96.83M |
| Accounts Payable | $3.90M | $3.24M | $2.75M | $3.89M | $4.06M | $3.88M | $1.53M | $4.32M |
| Total Current Liabilities | $16.46M | $11.40M | $11.70M | $15.15M | $15.68M | $15.53M | $10.68M | $14.97M |
| Total Non-Current Liabilities | $9.55M | $9.84M | $10.21M | $10.57M | $10.93M | $11.35M | $11.70M | $12.03M |
| Total Liabilities | $26.01M | $21.23M | $21.91M | $25.71M | $26.61M | $26.88M | $22.38M | $27.00M |
| Total Debt (incl. Leases) | $10.92M | $11.30M | $11.70M | $12.03M | $12.36M | $12.68M | $12.99M | $13.28M |
| Common Stock | $100K | $98K | $98K | $98K | $98K | $93K | $89K | $84K |
| Retained Earnings | -$645.5M | -$627.3M | -$617.0M | -$606.2M | -$592.2M | -$566.5M | -$546.9M | -$532.0M |
| Accumulated Other Comp. Income | -$92K | -$68K | -$70K | -$8.0K | -$1.0K | -$75K | -$66K | -$40K |
| Total Stockholders' Equity | $33.98M | $48.79M | $57.93M | $67.48M | $80.23M | $74.84M | $75.05M | $70.02M |
| Total Equity | $33.79M | $48.59M | $57.74M | $67.29M | $80.04M | $74.66M | $74.86M | $69.83M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$74.12M | -$64.02M | -$50.40M | -$45.34M | -$33.78M | -$16.23M | -$23.76M | -$34.52M | -$48.21M | -$57.85M |
| Depreciation & Amortization | $664K | $708K | $592K | $232K | $475K | $569K | $635K | $746K | $713K | $900K |
| Stock-Based Compensation | $5.00M | $2.99M | $2.60M | $2.15M | $1.61M | $1.47M | $1.78M | $3.43M | $6.78M | $5.03M |
| Operating Cash Flow | -$61.99M | -$69.12M | -$33.22M | -$41.89M | -$33.08M | -$15.30M | -$20.01M | -$31.06M | -$42.36M | -$52.86M |
| Capital Expenditure | -$77K | -$65K | -$4.21M | -$1.64M | -$192K | -$202K | -$79K | -$594K | -$1.31M | -$600K |
| Free Cash Flow | -$62.06M | -$69.18M | -$37.44M | -$43.53M | -$33.27M | -$15.50M | -$20.09M | -$31.66M | -$43.68M | -$53.46M |
| Purchases of Investments | -$93.44M | -$69.10M | -$107.0M | -$42.12M | -$126.5M | -$21.07M | -$40.65M | -$40.30M | -$77.67M | -$28.09M |
| Investing Cash Flow | -$5.05M | $17.23M | -$20.13M | $47.24M | -$91.57M | $6.90M | $4.92M | $37.17M | -$27.64M | $33.53M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $14K | $186K | $20K |
| Financing Cash Flow | $66.01M | $39.86M | $66.23M | $5.45M | $110.0M | $16.14M | $1.34M | -$4.24M | $52.70M | $4.70M |
| Net Change in Cash | -$1.03M | -$12.02M | $12.88M | $10.81M | -$14.62M | $7.74M | -$13.75M | $1.87M | -$17.30M | -$14.64M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.26M | -$10.31M | -$10.79M | -$13.96M | -$25.75M | -$19.53M | -$14.88M | -$14.97M |
| Depreciation & Amortization | $171K | $168K | $162K | $166K | $165K | $166K | $167K | $175K |
| Stock-Based Compensation | $2.59M | $1.15M | $1.31M | $1.21M | $1.31M | $1.30M | $1.18M | $770K |
| Operating Cash Flow | -$9.51M | -$9.35M | -$12.52M | -$12.20M | -$20.48M | -$13.89M | -$15.42M | -$13.13M |
| Capital Expenditure | -$45K | -$73K | -$138K | -$31K | -$37K | -$9.0K | $0 | -$25K |
| Free Cash Flow | -$9.56M | -$9.42M | -$12.65M | -$12.23M | -$20.51M | -$13.90M | -$15.42M | -$13.16M |
| Purchases of Investments | -$14.73M | -$7.98M | -$5.87M | -$12.85M | -$39.34M | -$18.16M | -$23.11M | -$26.07M |
| Investing Cash Flow | $5.72M | $15.32M | $11.49M | $16.44M | -$20.38M | $3.30M | -$4.42M | -$6.08M |
| Financing Cash Flow | $773K | -$129K | -$142K | -$131K | $29.62M | $17.90M | $18.63M | $18.84M |
| Net Change in Cash | -$3.01M | $5.84M | -$1.17M | $4.12M | -$11.24M | $7.30M | -$1.21M | -$378K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -40856.3% | -28899.6% | -15557.8% | -446.8% | -- | -152.2% | -5445.0% | -- | -- | -- |
| Net Profit Margin | -39009.5% | -27243.8% | -14274.5% | -436.5% | -- | -155.2% | -3844.5% | -- | -- | -- |
| Return on Equity (ROE) | -109.8% | -91.4% | -55.6% | -63.4% | -30.9% | -51.3% | -76.6% | -102.6% | -75.0% | -92.1% |
| Return on Assets (ROA) | -79.7% | -66.1% | -41.8% | -47.3% | -29.2% | -41.9% | -44.8% | -65.4% | -53.9% | -71.8% |
| Current Ratio | 5.30x | 5.48x | 6.27x | 5.83x | 18.89x | 6.06x | 2.47x | 4.69x | 8.37x | 8.77x |
| Quick Ratio | 5.19x | 4.82x | 5.98x | 4.77x | 17.95x | 5.40x | 2.41x | 4.57x | 8.19x | 8.46x |
| Debt to Equity | 0.18x | 0.19x | 0.17x | 0.20x | 0.01x | 0.07x | 0.55x | 0.48x | 0.31x | 0.15x |
| Revenue Growth (YoY) | -19.1% | -33.4% | -96.6% | -- | -100.0% | +2377.5% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.8% | -97.5% | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -40856.3% | -41395.3% | -- | -- | -28899.6% |
| Net Profit Margin | -- | -- | -- | -39009.5% | -39537.9% | -- | -- | -27243.8% |
| Return on Equity (ROE) | -156.9% | -124.6% | -120.9% | -109.8% | -93.6% | -89.0% | -84.5% | -91.4% |
| Return on Assets (ROA) | -89.2% | -87.1% | -87.9% | -79.7% | -70.4% | -65.6% | -65.2% | -66.1% |
| Current Ratio | 3.05x | 5.12x | 5.78x | 5.30x | 5.93x | 5.63x | 7.79x | 5.48x |
| Quick Ratio | 2.96x | 5.04x | 5.69x | 5.19x | 5.43x | 5.17x | 7.15x | 4.82x |
| Debt to Equity | 0.32x | 0.23x | 0.20x | 0.18x | 0.15x | 0.17x | 0.17x | 0.19x |
| Revenue Growth (YoY) | -100.0% | -- | -- | -- | -- | -- | -100.0% | -- |